Riskpilot← Back to searchSign inGet full accessMedtech Maze AB
ABActiveOrg 5568609464Polhemsgatan 18Business and other management consultancy activities · NACE 7020Est. 20111-4 employees
Revenue 2025
SEK 1,8M
-44% vs 2024
EBITDA margin
-13.3%
-5666% vs 2024
Equity ratio
31.3%
Financial strength
Net profit 2025
SEK -54K
-2190% vs 2024
| Revenue | SEK 1,8M | -44% |
| EBITDA | SEK -240K | -5666% |
| Net profit | SEK -54K | -2190% |
| Total assets | SEK 242K | -78% |
| Equity | SEK 76K | -81% |
| Employees | — | — |
Legal name
Medtech Maze AB
Org number
5568609464
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
11 augusti 2011
Share capital
SEK 35 500
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Aspered Jonasson, Anna Paulina
Company purpose
Bolaget ska bedriva e-hälsotjänster, konsulttjänster i anslutning därtill samt därmed förenlig verksamhet.
Address
Polhemsgatan 18
Email
paulina@medtechmaze.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 149 | 2 208 | 2 448 | 3 249 | 1 811 |
| Staff expenses | — | — | −1 918 | −1 872 | −602 |
| EBITDA | 281 | 114 | 67 | −4 | −240 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 281 | 114 | 67 | −4 | −240 |
| Net financials | — | −1 | −5 | −5 | −4 |
| Profit before tax | 241 | 82 | 70 | 10 | −54 |
| Tax | −50 | −19 | −17 | −7 | — |
| Net profit | 191 | 63 | 53 | 3 | −54 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 929 | 1 025 | 973 | 1 119 | 242 |
| Equity | 283 | 347 | 399 | 402 | 76 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 458 | 461 | 365 | 528 | 166 |
| Total debt | 458 | 461 | 365 | 528 | 166 |
EBITDA margin
-13.3%
This company
15.8%
Market median
-184% vs market
20212025
Equity ratio
31.3%
This company
38.2%
Market median
+18% vs market
20212025
Return on equity
-71.6%
This company
18.4%
Market median
-489% vs market
20212025
Net profit margin
-3.0%
This company
8.1%
Market median
-137% vs market
20212025
Asset turnover
7.50×
This company
1.12×
Market median
+570% vs market
20212025
Debt / equity
2.19×
This company
0.62×
Market median
-253% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AP Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (4) | ||
| Chairman | 2023 – 2023 | |
| Chairman | 2022 – 2025 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SHORTCUT AS
Medtech Maze AB Board members of Medtech Maze AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Paulina Aspered Jonasson | Chief Executive Officer | 0 companies |
| Gabriel Lars Sabadin | Chairman | 0 companies |
| Sebastian Björn Gunnar Stern | Chairman | 0 companies |
| Sandra Ulrika Kastås | Board of Directors | 0 companies |
| Thomas Börje Ehrengren | Board of Directors | 0 companies |
| Maria Emelia Kessling | Chairman | 0 companies |
| Christian Rikard Tärnholm | Chairman | 0 companies |